The literature on childhood elective/selective mutism and its relationship to social phobia is reviewed briefly. A chronic case, resistant to multiple psychological treatments, is described. The results of a novel treatment approach with moclobemide, a reversible monoamine oxidase inhibitor, are evaluated and discussed.
American Psychiatric Association
. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press.
2.
Black, B.
, & Uhde, T.W. (1992). Elective mutism as a variant of social phobia. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 1090-1094.
3.
Black, B.
, & Uhde, T.W. (1995). Psychiatric characteristics of children with selective mutism: A pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 847-856.
4.
Dow, S.P.
, Sonies, B.C., Scheib, D., Moss, S.E., & Leonard, H.L. (1995). Practical guidelines for the assessment and treatment of selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 836-846.
5.
Dummit, E.S.
, Klein, R.G., Tancer, N.K., Asche, B.C., Martin, J., & Fairbanks, J.A. (1997). Systematic assessment of 50 children with selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 653-660.
6.
Finberg, J.
(1995). Pharmacology of reversible and selective inhibitors of monoamine oxidase type A. Acta Psychiatrica Scandinavica, 91(Suppl. 386), 8-13.
7.
Fundudis, T.
, Kolvin, I., & Garside, R. (1979). Speech retarded and deaf children: Their psychological development. London: Academic Press.
8.
Golwyn, D.
, & Weinstock, R. (1990). Phenelzine treatment of elective mutism: A case report. Journal of Clinical Psychiatry, 51, 384-385.
9.
Jacobsen, T.
(1994). Case study: Is selective mutism a manifestation of dissociative identity disorder?Journal of the American Academy of Child and Adolescent Psychiatry, 34, 863-866.
10.
Kolvin, I.
, & Fundudis, T. (1981). Elective mute children: Psychological development and background factors. Journal of Child Psychology and Psychiatry, 22, 219-232.
11.
Liebowitz, M.
, Schneier, F., Gitow, A., & Feerick, J. (1993). Reversible monoamine oxidase-A inhibitors in social phobia. Clinical Neuropharmacology, 16(Suppl.), S83-S88.
12.
MacGregor, R.
, Pullar, A., & Cundall, D. (1994). Silent at school – Elective mutism and abuse. Archives of Disease in Childhood, 70, 540-541.
13.
Noyes, R. Jr
, Moroz, G., Davidson, J.R., Liebowitz, M.R., Davidson, A., Siegel, J., Bell, J., Cain, J.W., Curlik, S.M., Kent, T.A., Lydiard, R.B., Mallinger, A.G., Pollack, M.H., Rapaport, M., Rasmussen, S.A., Hedges, D., Schweizer, E., & Uhlenhuth, E. (1997). Moclobemide in social phobia: A controlled dose–response trial. Journal of Clinical Psychopharmacology, 17, 247-254.
14.
Powell, S.
, & Dalley, M. (1995). When to intervene in selective mutism: The multimodal treatment of a case of persistent selective mutism. Psychology in the Schools, 32, 115-123.
15.
Szabo, C.
(1996). Selective mutism and social anxiety. [Letter to the Editor.]Journal of the American Academy of Child and Adolescent Psychiatry, 35, 555.
16.
Tancer, N.K.
(1992). Elective mutism: A review of the literature. In B.B. Lahey & A.E. Kazdin (Eds.), Advances in clinical child psychology (Vol 14, pp. 265-288). New York: Plenum Press.
17.
Trott, G.E.
, Friese, H.J., Menzel, M., & Nissen, G. (1992). Use of moclobemide in children with attention deficit hyperactivity disorder. Psychopharmacology (Berlin), 106(Suppl.), S134-S136.
18.
Wright, H.H.
, Holmes, G.R., Cuccaro, M.L., & Leonhardt, T.V. (1994). A guided bibliography of the selective mutism (elective mutism) literature. Psychological Reports, 74, 995-1007.
